Comment on: Endogenous retroviruses expressed in human tumours cannot be used as targets for anti-tumour vaccines

• Amaia Vergara Bermejo,
• Karen Nørgaard Nielsen,
• Peter Johannes Holst

Affiliations

Amaia Vergara Bermejo

InProTher ApS, BioInnovation Institute, Copenhagen Bio Science Park, 2200 Copenhagen, Denmark; Department of Biomedical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark

Karen Nørgaard Nielsen

InProTher ApS, BioInnovation Institute, Copenhagen Bio Science Park, 2200 Copenhagen, Denmark

Peter Johannes Holst

InProTher ApS, BioInnovation Institute, Copenhagen Bio Science Park, 2200 Copenhagen, Denmark; Center for Medical Parasitology, Department of Immunology and Microbiology, University of Copenhagen, 2200 Copenhagen, Denmark; Correspondence